zoriden Thursday, 02/20/14 08:41:53 PM Re: None 0 Post # of 46215 My conversation with PUNIT DHILLON ZORIDEN: First question i asked was in regards to neopulse in Europe and why it has not been mentioned in the last 3 months? RESPONSE: There core focus is immunopulse but neopulse has had many partnership offers which they have refused do to not a huge benefit to the company and the shareholders.They want what it's worth not just to say they have a partnership.There is a few companies that are more lining up with what ONCS would like but details can not be given, and no deal has been inked yet! What he really expounded upon and what has me so excited was the fact he knows what they have and they are not going to take less than what it's worth ZORIDEN: This was more of what i asked of him and if he would like to elaborate on.I said that with the core group of investors and more and more coming in, with all the catalysts we have in 2014. Give us the year to organically grow the share structure and not utilize a R/S.. RESPONSE: As of now that is not even a thought the stock is moving on it's own and this is a big year for Oncosec.One of the big things he learned from INO when he did a R/S was the aftermath.And the only reason he would do a R/S is if the stock was not moving and only to uplist but that will not happen for unless things change.He agreed that the organic way was the best way but if need be they would consider it. ZORIDEN: In regards to IL-12 with INO and the Pfizer electroporation deal with the San Diego company. RESPONSE: INO uses IL-12 as a vaccine in the muscle they can not use it in tumors only ONCS can.He stated that anyone wanting to use IL-12 in combination with tumors will have to go through ONCS..In regards to Pfizer he chuckled.He stated INO and ONCS have the best electroporation out there and Pfizer was looking for a lower price cheaper alternative.With a back door kind of method.Day late and a dollar short. ZORIDEN: MERKEL cell melanoma do you get granted or do you have to file for orphan status? RESPONSE: You have to file for it but there is no point now because the FDA will want to see the MCC stage 2 trials.So once that is done the filing will happen. Zoriden: Would you be surprised if you do not have a partner by the end of 2014? RESPONSE: YES, there is interest in possible funding for our stage 3's again they will not just take a partnership for the sake of a partnership nothing is set in stone. Don't any one go saying they will have a partner.The trials still have to be good.They are going to get the most of "THE GOLDEN EGGS they are sitting on".They are in the research field so the partner they do join forces with will be the ones bringing there (ONCS) drugs to market.Oncosec at this time is not equiped to market drugs. ZORIDEN: Do you see you selling this company?Or bringing it to market? RESPONSE: WE would like to see it go to market but we can't say we would not accept a buyout. But that number we have not even thought of.But he Alluded it to being alot. ZORIDEN: Where do you see ONCOSEC in the next 2-5 years? RESPONSE: Well we are growing quickly we are in the process of hiring 10 more people we have doubled in size in under 2 years.I see us having a drug FDA approved and commercialized.We are sitting on 3 Golden eggs and we are not stopping there.We will have another drug in trials by years end and more to come in following years with the potential of using other drugs in combination.We are at the forefront of immunotherapy and we have a platform that we can continue to expand upon.We have DR. Robert Pierce who was looking for what would work to turn the human body to accept PD-1s and he found it here with ONCOSEC and if he see's what we have and we will use that as leverage with a partnership. This was our conversation not word for word but close so don"t assume, expect, or over estimate that all things can change.This was the jist of our conversation and i am very pleased i was able to speak with him...Most of this was from memory and as close as i can recall. No names no dates no forward looking statements were given other than potentials...Thanks I am very excited with our future here! $ONCS My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.